Consolidated Balance Sheet (Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 88,079	$ 68,513
Receivables	12,914	14,516
Total current assets	100,993	83,029
Investment in equity method investee	439,559	450,683
Total assets	540,552	533,712
Current liabilities
Accounts payable and accrued liabilities	246,820	225,430
Due to related parties	11,750	11,750
Loans payable	38,067
Convertible notes payable, net of discount	73,103	20,000
Derivative liability	89,145
Settlement liability	106,961	360,756
Total current liabilities	565,846	617,936
Total liabilities	565,846	617,936
Stockholders' Equity (Deficit)
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	400	400
Common stock; $0.0001 par value; 100,000,000 shares authorized; 12,879,452 and 2,435,179 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively.	1,288	446
Additional paid-in capital	18,486,268	15,404,716
Accumulated deficit	(18,513,454)	(15,489,993)
Total stockholders' equity (deficit)	(25,294)	(84,224)
Total liabilities and stockholders' equity deficit	540,552	533,712
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding		7
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	200	200
Series D Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred stock, 10,000,000 shares authorized, $0.0001 par value, 4,000,000 issued and outstanding	$ 4